H.R. 8000: End Needless Distribution of 7-OH Act

This bill is designed to modify the Controlled Substances Act by classifying synthetic 7-hydroxymitragynine (7-OH) as a Schedule I controlled substance. Below are the key points of what the bill entails:

Definition of 7-Hydroxymitragynine

7-hydroxymitragynine is a substance derived from the kratom plant, known scientifically as Mitragyna speciosa. The bill specifically targets synthetic versions of this compound, stating:

• 7-hydroxymitragynine, including its synthetic equivalents, will be classified as a controlled substance.
• Natural forms of 7-hydroxymitragynine found in the kratom plant will not be included in this classification.

Purpose of the Bill

The purpose of designating synthetic 7-hydroxymitragynine as a Schedule I substance is to regulate and control its distribution and use. Schedule I substances are defined as having a high potential for abuse, no accepted medical use, and a lack of accepted safety for use under medical supervision.

Implications of Classification

By classifying synthetic 7-hydroxymitragynine as a Schedule I controlled substance:

• The manufacturing, distribution, and possession of synthetic 7-OH will be strictly regulated.
• Entities involved in the production or distribution of synthetic 7-OH will be subject to legal penalties if they do not comply with the established regulations.
• This action aims to limit potential health risks associated with the use of synthetic variants of this compound.

Exclusions

It is important to note that the bill specifically excludes forms of 7-hydroxymitragynine that occur naturally in kratom. This means that while synthetic versions will be banned, naturally occurring 7-hydroxymitragynine will remain legal and available.

Legislative Process

The bill was introduced in the House of Representatives and has been referred to the Committee on Energy and Commerce and the Committee on the Judiciary for further consideration. The legislative process will assess the implications and effectiveness of this amendment to the Controlled Substances Act.

Relevant Companies

None found.